Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
about
Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cellsThe obesity of boneAdipokines, metabolic syndrome and rheumatic diseasesThe endocrine function of adipose tissue: an updateAlternative splicing generates a novel non-secretable resistin isoform in Wistar ratsAdiponectin and resistin in the neonatal rat: effects of dexamethasone and hypoxiaThe Role of Adipokines in Understanding the Associations between Obesity and Depression.Serum resistin level in obese male childrenControl of body weight: a physiologic and transgenic perspective.Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome.Resistin - 420 C/G polymorphism and serum resistin level in Iranian patients with gestational diabetes mellitus.Association of Resistin with Insulin Resistance and Factors of Metabolic Syndrome in North Indians.Cord blood resistin and adiponectin in term newborns of diabetic mothers.Resistin does not down-regulate the transcription of insulin receptor promoter.Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary resultsInfluence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk.Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?Bioinformatic analysis of functional proteins involved in obesity associated with diabetes.Indices of low-grade inflammation in polycystic ovary syndrome.Nutrigenomics, beta-cell function and type 2 diabetesLeptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review.Adipokines and cardiovascular risk in Cushing's syndrome.Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review.Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.S 23521 decreases food intake and body weight gain in diet-induced obese rats.Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population.Efficacy of omega-3 in the treatment of polycystic ovary syndrome.Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters.
P2860
Q26744596-A112C064-F8BB-4513-A4EC-61729F4487D2Q26775713-A4062A59-E4D7-4030-A1D8-429EBF17D398Q26865268-6908CB3B-F6EF-48E8-B099-C56259ACF88BQ28305131-6044CF78-1F7A-4A44-BF72-D163BC798FE1Q28572946-DCB08D16-DA07-4D9E-80B1-F7EDE663966BQ28581929-1C945AD1-A4EC-48EE-BF22-DD83F1F2F87EQ34078096-C55C6D96-F567-4AA4-8549-0888BF5F8BE9Q34974967-C13076B1-FDB2-433C-B221-A7E35D8015D5Q35081751-A7795B73-0766-4110-881A-2FA1C35E6AC0Q35245193-88786633-AB36-443A-B834-0F1905590A70Q35568653-0F395149-84C0-4BFA-A30A-B435D136CF2CQ35747118-858FAB57-411E-4A94-BB4F-C16E6A148ABBQ35770765-B2C6444D-0239-407C-8E52-E567239AFC25Q36513017-50E7443E-F238-45DF-9020-EA19B6042C83Q36516331-E5DEFE73-5C42-4674-8C66-2697159FDEDBQ36582321-85EE535D-1E7E-4FC3-A6CB-10A7A996A5A2Q36632433-F020CB07-1377-43F5-A0D6-8FEE5DD8010DQ36735365-B806A6C5-7066-4F92-BA52-185CC3450C87Q36739203-85501203-6696-411E-96FF-3145FBBCADC0Q36775874-A290BAF0-124D-4D7A-AF2C-81D61E699D0BQ36849442-7C29CA9E-92DD-4ACA-AB58-3DBF4A1EAB73Q37349807-3EB75520-1166-4188-934F-24543CD59877Q37953199-8E51AFA8-75BC-43E1-92F9-ABA86D34F511Q38644618-3EC82DA7-8888-4066-85FA-372BC36EC304Q44584057-E76D18CC-CBC5-4011-ADA0-677078FE9EFCQ45145890-AA62BFF7-248F-4ED7-B106-9608AD798470Q46147587-8EDB49CB-146D-43E8-B5E3-EDA5FE86647AQ46824323-65328F02-06BD-41F8-A139-F1E483B6830DQ51342320-D6993ABF-B119-44F0-A53A-927065AF5494Q51787442-FB5F22D1-7B82-4456-983E-3782EBB3BD2C
P2860
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
@ast
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
@en
type
label
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
@ast
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
@en
prefLabel
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
@ast
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
@en
P356
P1476
Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
@en
P2093
Olavi Ukkola
P304
P356
10.1530/EJE.0.1470571
P577
2002-11-01T00:00:00Z